Mettler-Toledo International (NYSE:MTD) Upgraded by Bank of America to “Buy” Rating

Mettler-Toledo International (NYSE:MTD) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a research report issued on Monday. The brokerage currently has a $1,600.00 price objective on the medical instruments supplier’s stock. Bank of America‘s price objective would indicate a potential upside of 13.24% from the stock’s previous close.

MTD has been the subject of several other reports. Morgan Stanley assumed coverage on Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price objective for the company. The Goldman Sachs Group started coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Stifel Nicolaus increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Wells Fargo & Company boosted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Finally, JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and a consensus target price of $1,441.67.

Mettler-Toledo International Trading Up 1.4%

MTD stock opened at $1,412.95 on Monday. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,525.17. The firm has a market cap of $28.87 billion, a PE ratio of 35.17, a P/E/G ratio of 4.50 and a beta of 1.40. The business’s 50-day moving average price is $1,402.13 and its two-hundred day moving average price is $1,293.95.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. During the same quarter last year, the firm posted $10.21 earnings per share. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider La Guerroniere Marc De sold 6,880 shares of the stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the transaction, the insider directly owned 187 shares of the company’s stock, valued at $271,150. This represents a 97.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 1,895 shares of Mettler-Toledo International stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,696,789.76. The trade was a 26.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 19,565 shares of company stock valued at $28,683,737. Corporate insiders own 0.77% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several institutional investors have recently added to or reduced their stakes in the company. Allworth Financial LP raised its stake in Mettler-Toledo International by 6.1% in the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after purchasing an additional 7 shares in the last quarter. IFP Advisors Inc boosted its stake in shares of Mettler-Toledo International by 23.3% in the third quarter. IFP Advisors Inc now owns 111 shares of the medical instruments supplier’s stock valued at $136,000 after buying an additional 21 shares during the period. Swiss Life Asset Management Ltd grew its position in Mettler-Toledo International by 13.5% during the third quarter. Swiss Life Asset Management Ltd now owns 3,950 shares of the medical instruments supplier’s stock worth $4,849,000 after buying an additional 470 shares in the last quarter. Investment Research Partners LLC acquired a new stake in Mettler-Toledo International during the third quarter worth approximately $654,000. Finally, CIBC Bancorp USA Inc. bought a new position in Mettler-Toledo International during the 3rd quarter worth $3,496,000. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.